KEGG: ect:ECIAI39_3983
Recombinant E. coli O7:K1 Universal stress protein B (uspB) is a 111-amino acid membrane-associated protein with the sequence "MISTVALFWALCVVCIVNMARYFSSLRALLVVLRNCDPLLYQYVDGGGFFTSHGQPNKQVRLVWYIYAQRYRDHHDDEFIRRCERVRRQFILTSALCGLVVVSLIALMIWH" . The protein contains hydrophobic regions consistent with membrane localization, particularly at its N-terminal and C-terminal domains. When expressed recombinantly with an N-terminal His-tag, the protein is typically purified as a lyophilized powder with purity greater than 90% as determined by SDS-PAGE .
The Universal Stress Protein (USP) family in E. coli consists of several members including UspA, UspC (YecG), UspD (YiiT), UspE (YdaA), UspF (YnaF, UP03), and UspG (YbdQ) . These proteins have been divided into three subfamilies based on their sequence and functional characteristics. Additionally, E. coli USPs are categorized into two major classes and four minor subclasses . The uspB protein represents an additional member of this family that functions within the complex network of stress response mechanisms in E. coli, particularly in the context of membrane-associated stress responses based on its sequence characteristics.
For recombinant expression of uspB from E. coli O7:K1, the following methodology is recommended:
Clone the full-length gene (positions 1-111) into an expression vector containing an N-terminal His-tag.
Transform the construct into an E. coli expression strain suitable for membrane protein expression.
Induce protein expression under optimal conditions (typically with IPTG for T7-based systems).
Harvest cells and lyse using appropriate detergents that solubilize membrane proteins.
Purify using Ni-NTA affinity chromatography, taking care to include detergents in all buffers.
Consider reconstitution methods if functional studies are planned.
For storage, lyophilization in a Tris/PBS-based buffer with 6% trehalose (pH 8.0) has proven effective . Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL, adding 5-50% glycerol for long-term storage at -20°C/-80°C .
To investigate potential relationships between uspB and K1 capsule formation, researchers should employ a multifaceted approach:
Gene knockout studies: Create a uspB deletion mutant using λ-red recombineering or thermosensitive allelic replacement using the plasmid pKO3blue . Compare capsule expression between wild-type and mutant strains using flow cytometric analysis with rEndoNA2-GFP, which specifically targets polySia K1 capsule .
Complementation experiments: Reintroduce uspB on a plasmid to confirm phenotype restoration.
Serum resistance assays: Compare the susceptibility of wild-type and uspB mutant strains to complement C3b deposition and serum killing as described by Sarowska et al. , where bacteria are incubated in human serum and survival rates are quantified.
Co-expression analyses: Examine expression patterns of uspB alongside known K1 capsule genes (such as those in the K1-cps locus) under various stress conditions.
Protein-protein interaction studies: Use pull-down assays or bacterial two-hybrid systems to identify potential interactions between UspB and proteins involved in capsule biosynthesis.
When confronting contradictory data regarding uspB's role in stress response:
Standardize strain backgrounds: Ensure experiments use identical genetic backgrounds, as subtle strain differences can influence stress responses. Consider using both laboratory K-12 derivatives and clinically relevant O7:K1 strains.
Define precise stress conditions: USPs respond differently to various stressors . Design experiments with precisely controlled stress parameters including:
Type of stress (oxidative, osmotic, pH, nutrient limitation)
Intensity of stress
Duration of exposure
Growth phase during stress application
Use multiple readouts: Combine transcriptional analysis (RT-qPCR), protein expression monitoring (Western blot), and phenotypic assays (growth curves, survival rates).
Time-course experiments: USP effects may be transient or growth phase-dependent. The phenotype of uspA deletion mutants becomes apparent only during transition to stationary phase after several generations of growth .
Consider redundancy: Multiple USP proteins may have overlapping functions. Generate combinations of usp gene deletions to overcome functional redundancy .
Environmental relevance: Test conditions mimicking natural habitats of E. coli O7:K1, such as human serum or cerebrospinal fluid.
To characterize ATP-binding properties of uspB and compare with other USP family members:
Structural analysis:
Binding assays:
Isothermal titration calorimetry (ITC) to determine binding constants
Fluorescence-based assays using ATP analogs like TNP-ATP
Filter binding assays with radiolabeled ATP
Mutational analysis:
Identify potential ATP-binding residues by sequence alignment with known ATP-binding USPs
Generate point mutations in these residues
Test mutant proteins for altered ATP binding properties
Functional correlation:
Assess how ATP binding affects uspB's role in stress response
Test uspB ATP-binding mutants for complementation of phenotypes in uspB deletion strains
Comparative analysis:
Systematically compare ATP binding parameters (Kd, binding kinetics) across USP family members
Correlate binding differences with functional differences
To investigate uspB's contribution to E. coli O7:K1 virulence:
Generation of isogenic strains:
In vitro virulence assays:
Animal infection models:
Bacteremia model: Intravenous infection to assess persistence in bloodstream
Urinary tract infection model: Transurethral inoculation to assess colonization and ascending infection
Neonatal meningitis model: Appropriate for K1 strains which are associated with neonatal meningitis
Immune response characterization:
In vivo imaging:
Use bioluminescent or fluorescent reporter strains to track infection progression in real-time
To comprehensively analyze uspB regulation:
Transcriptional analysis:
Construct transcriptional fusions (uspB promoter-reporter) using systems like lacZ, GFP, or luciferase
Perform RT-qPCR under various conditions (stress conditions, growth phases)
Map transcription start sites using 5' RACE or primer extension
Identify transcription factor binding sites through ChIP-seq or DNA footprinting
Stress condition testing matrix:
Carbon source limitation (glucose starvation)
Phosphate limitation
Oxidative stress (H2O2, superoxide generators)
Heat shock
DNA damage (mitomycin C, UV)
pH stress
Osmotic stress
Transition to stationary phase
Regulatory network mapping:
Test uspB expression in strains lacking known stress regulators (rpoS, cysB)
Perform RNA-seq to identify co-regulated genes
Use transposon mutagenesis to identify novel regulators
Post-transcriptional regulation:
Analyze mRNA stability under different conditions
Investigate potential small RNA regulators
Examine translational efficiency using ribosome profiling
Comparative analysis:
Compare regulation patterns with other USP family members
Examine differences between laboratory K-12 and pathogenic O7:K1 strains
To characterize uspB membrane topology and interaction partners:
Membrane topology determination:
Construct fusion proteins with topology reporters (PhoA, LacZ, GFP)
Perform cysteine accessibility methods with membrane-impermeable reagents
Use protease protection assays
Apply nanodiscs or liposome reconstitution for structural studies
Protein-protein interaction identification:
Bacterial two-hybrid screening
Co-immunoprecipitation with epitope-tagged uspB
Crosslinking followed by mass spectrometry
Proximity labeling approaches (BioID, APEX)
Split-GFP complementation assays for validation
Functional validation of interactions:
Co-expression studies
Mutational analysis of interaction interfaces
Competitive inhibition of interactions
Phenotypic characterization of interaction-deficient mutants
Spatial organization in the cell:
Super-resolution microscopy to visualize uspB localization
Co-localization studies with known membrane proteins
Fractionation studies to determine membrane microdomain associations
Dynamics of interactions:
FRET or BRET assays to monitor real-time interactions
Single-molecule tracking to analyze diffusion properties and clustering
To compare uspB function across pathogenic E. coli strains:
Comparative genomics approach:
Analyze uspB sequence conservation across UPEC, EHEC, EPEC, ETEC, and other pathotypes
Identify strain-specific variations in uspB sequence or regulatory regions
Construct phylogenetic trees of uspB sequences to correlate with pathotype classification
Functional complementation studies:
Express uspB variants from different strains in a common genetic background
Test complementation of stress response phenotypes
Assess contribution to virulence-associated traits
Expression pattern analysis:
Compare uspB expression levels across strains under identical conditions
Determine if regulation differs between pathotypes
Correlate expression patterns with virulence potential
Heterologous strain testing:
Generate mutants in multiple strain backgrounds
Test for strain-specific phenotypes
Identify genetic interactions unique to specific backgrounds
A comparative analysis table can be constructed:
| Pathotype | Representative Strain | uspB Sequence Identity (%) | Key Amino Acid Substitutions | Expression Pattern | Major Phenotypic Effects |
|---|---|---|---|---|---|
| UPEC | UTI89 | [Data required] | [Data required] | [Data required] | [Data required] |
| EHEC | O157:H7 | [Data required] | [Data required] | [Data required] | [Data required] |
| NMEC | O7:K1 | 100% (reference) | None (reference) | [Data required] | [Data required] |
| EPEC | E2348/69 | [Data required] | [Data required] | [Data required] | [Data required] |
| ETEC | H10407 | [Data required] | [Data required] | [Data required] | [Data required] |
To investigate the relationship between uspB and K1 capsule in immune evasion:
Sequential experimental design:
Immune evasion assays:
Cross-complementation studies:
Determine if overexpression of K1 capsule genes can compensate for uspB mutation
Test if uspB overexpression affects phenotypes of K1 capsule-deficient strains
Regulatory interaction mapping:
ChIP-seq to identify potential direct regulatory relationships
RNA-seq to identify co-regulated gene networks
Protein-protein interaction studies between UspB and K1 capsule biosynthesis proteins
Therapeutic targeting assessment:
Test capsule depolymerase (rEndoE) effectiveness on uspB mutants
Evaluate synergistic effects of targeting both uspB and K1 capsule simultaneously
For optimal purification and functional analysis of recombinant uspB:
Expression optimization:
Test multiple E. coli expression strains (BL21(DE3), C41(DE3), C43(DE3) for membrane proteins)
Optimize induction conditions (temperature, IPTG concentration, duration)
Consider inclusion of detergents during expression to improve solubility
Purification protocol:
Cell lysis: Use gentle methods like enzymatic lysis with lysozyme followed by brief sonication
Detergent screening: Test multiple detergents (DDM, LDAO, Triton X-100) for optimal extraction
Affinity purification: Ni-NTA chromatography with imidazole gradient elution
Size exclusion chromatography: Remove aggregates and further purify
Quality control assessments:
Functional reconstitution options:
Liposome reconstitution
Nanodisc incorporation
Amphipol stabilization
Storage conditions:
To address functional redundancy when studying uspB:
Systematic mutation approach:
Generate single, double, and multiple deletions of usp family genes
Create a complete set of uspB+other usp double mutants
Construct strains with only uspB remaining (deletion of all other usp genes)
Phenotypic screening matrix:
Test each mutant combination under multiple stress conditions
Focus on conditions where single mutants show subtle or no phenotypes
Look for synergistic effects in multiple mutants
Specific vs. overlapping functions:
Use transcriptomics to identify genes specifically regulated by uspB
Compare protein interaction networks of different USPs
Identify conditions where uspB expression patterns differ from other USPs
Domain-swapping experiments:
Create chimeric proteins with domains from different USPs
Test complementation of specific phenotypes
Identify functional domains unique to uspB
Controlled expression systems:
Use inducible promoters to express uspB at defined levels
Compensate for loss of multiple USPs with controlled uspB expression
Determine threshold levels needed for function